Eagle Asset Management Inc Abbott Laboratories Transaction History

Eagle Asset Management Inc

  • $16.7 Billion
  • Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Eagle Asset Management Inc holds 1,044,108 shares of ABT stock, worth $119 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
1,044,108
Previous 966,554 8.02%
Holding current value
$119 Million
Previous $100 Million 18.52%
% of portfolio
0.71%
Previous 0.56%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$100.07 - $118.13 $7.76 Million - $9.16 Million
77,554 Added 8.02%
1,044,108 $119 Million
Q2 2024

Aug 12, 2024
BUY
$100.73 - $112.44 $4.38 Million - $4.89 Million
43,472 Added 4.71%
966,554 $100 Million
Q1 2024

May 09, 2024
SELL
$109.52 - $120.96 $1.14 Million - $1.26 Million
-10,445 Reduced 1.12%
923,082 $105 Million
Q4 2023

Feb 12, 2024
SELL
$90.19 - $110.4 $2.88 Million - $3.53 Million
-31,964 Reduced 3.31%
933,527 $103 Million
Q3 2023

Nov 13, 2023
SELL
$95.53 - $114.62 $2.26 Million - $2.71 Million
-23,667 Reduced 2.39%
965,491 $93.5 Million
Q2 2023

Aug 09, 2023
BUY
$100.78 - $112.29 $15.8 Million - $17.6 Million
156,627 Added 18.81%
989,158 $108 Million
Q1 2023

May 08, 2023
BUY
$96.86 - $114.01 $33.6 Million - $39.5 Million
346,897 Added 71.43%
832,531 $84.3 Million
Q4 2022

Feb 14, 2023
BUY
$95.06 - $111.52 $9.99 Million - $11.7 Million
105,085 Added 27.61%
485,634 $53.3 Million
Q3 2022

Nov 07, 2022
BUY
$96.76 - $112.03 $616,070 - $713,295
6,367 Added 1.7%
380,549 $36.8 Million
Q2 2022

Aug 10, 2022
BUY
$102.07 - $123.37 $22.5 Million - $27.2 Million
220,877 Added 144.08%
374,182 $40.7 Million
Q1 2022

May 12, 2022
BUY
$114.02 - $139.04 $93,154 - $113,595
817 Added 0.54%
153,305 $18.1 Million
Q4 2021

Feb 11, 2022
SELL
$115.53 - $141.46 $424,572 - $519,865
-3,675 Reduced 2.35%
152,488 $21.5 Million
Q3 2021

Nov 10, 2021
BUY
$116.66 - $129.06 $70,345 - $77,823
603 Added 0.39%
156,163 $18.4 Million
Q2 2021

Aug 11, 2021
BUY
$105.79 - $124.53 $256,117 - $301,487
2,421 Added 1.58%
155,560 $18 Million
Q1 2021

May 14, 2021
BUY
$108.84 - $128.23 $6.89 Million - $8.12 Million
63,332 Added 70.52%
153,139 $18.2 Million
Q4 2020

Feb 12, 2021
SELL
$105.0 - $114.42 $5.84 Million - $6.36 Million
-55,590 Reduced 38.23%
89,807 $9.83 Million
Q3 2020

Nov 12, 2020
SELL
$91.64 - $111.29 $8.12 Million - $9.86 Million
-88,580 Reduced 37.86%
145,397 $15.3 Million
Q2 2020

Aug 12, 2020
SELL
$76.57 - $98.0 $5.78 Million - $7.4 Million
-75,527 Reduced 24.4%
233,977 $20.8 Million
Q1 2020

May 11, 2020
SELL
$62.82 - $91.86 $572,227 - $836,752
-9,109 Reduced 2.86%
309,504 $24.4 Million
Q4 2019

Feb 07, 2020
SELL
$78.51 - $87.4 $237,335 - $264,210
-3,023 Reduced 0.94%
318,613 $27.7 Million
Q3 2019

Nov 04, 2019
SELL
$81.84 - $88.74 $1.83 Million - $1.99 Million
-22,405 Reduced 6.51%
321,636 $26.9 Million
Q2 2019

Aug 05, 2019
SELL
$72.88 - $85.0 $6.76 Million - $7.88 Million
-92,700 Reduced 21.23%
344,041 $28.9 Million
Q1 2019

May 01, 2019
BUY
$66.22 - $80.06 $2.34 Million - $2.83 Million
35,386 Added 8.82%
436,741 $34.9 Million
Q4 2018

Feb 11, 2019
BUY
$65.56 - $74.27 $1.2 Million - $1.36 Million
18,252 Added 4.76%
401,355 $29 Million
Q3 2018

Nov 08, 2018
SELL
$60.81 - $73.36 $319,009 - $384,846
-5,246 Reduced 1.35%
383,103 $28.1 Million
Q2 2018

Aug 07, 2018
SELL
$57.57 - $63.54 $427,111 - $471,403
-7,419 Reduced 1.87%
388,349 $23.7 Million
Q1 2018

May 09, 2018
SELL
$56.27 - $63.62 $395,859 - $447,566
-7,035 Reduced 1.75%
395,768 $23.7 Million
Q4 2017

Feb 09, 2018
SELL
$53.68 - $57.47 $66.6 Million - $71.3 Million
-1,240,825 Reduced 75.49%
402,803 $23.3 Million
Q3 2017

Nov 09, 2017
BUY
$48.06 - $53.64 $79 Million - $88.2 Million
1,643,628
1,643,628 $88.2 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email